30 years of historical data (1996–2025) · Healthcare · Medical - Instruments & Supplies
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Pro-Dex, Inc. trades at 23.7x earnings, 20% above its 5-year average of 19.8x, sitting at the 62nd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.0x, the stock trades at a premium of 8%.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $203M | $147M | $70M | $69M | $60M | $120M | $73M | $56M | $29M | $25M | $23M |
| Enterprise Value | $219M | $163M | $81M | $81M | $75M | $135M | $73M | $53M | $24M | $21M | $21M |
| P/E Ratio → | 23.74 | 16.34 | 32.73 | 9.79 | 13.18 | 27.04 | 11.88 | 13.38 | 17.97 | 4.92 | 27.80 |
| P/S Ratio | 3.05 | 2.20 | 1.30 | 1.51 | 1.43 | 2.86 | 2.09 | 2.05 | 1.29 | 1.14 | 1.15 |
| P/B Ratio | 5.82 | 4.00 | 2.27 | 2.20 | 2.36 | 4.73 | 3.81 | 3.28 | 1.67 | 1.83 | 2.61 |
| P/FCF | — | — | 13.45 | 15.48 | — | — | 13.63 | 28.94 | 13.36 | 9.66 | 177.14 |
| P/OCF | — | — | 11.31 | 12.72 | — | — | 12.32 | 16.77 | 9.33 | 7.75 | 49.80 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Pro-Dex, Inc.'s enterprise value stands at 18.4x EBITDA, 28% above its 5-year average of 14.3x. The Healthcare sector median is 14.1x, placing the stock at a 30% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.45 | 1.51 | 1.76 | 1.79 | 3.22 | 2.10 | 1.94 | 1.06 | 0.96 | 1.04 |
| EV / EBITDA | 18.39 | 13.65 | 9.73 | 12.29 | 12.85 | 23.15 | 9.54 | 9.68 | 8.05 | 6.38 | 18.59 |
| EV / EBIT | 20.52 | 12.64 | 25.39 | 8.16 | 12.20 | 21.99 | 9.00 | 10.54 | 6.97 | 7.37 | 18.01 |
| EV / FCF | — | — | 15.54 | 18.12 | — | — | 13.74 | 27.29 | 10.98 | 8.08 | 160.18 |
Margins and return-on-capital ratios measuring operating efficiency
Pro-Dex, Inc. earns an operating margin of 16.1%. Operating margins have expanded from 12.5% to 16.1% over the past 3 years, signaling improving operational efficiency. ROE of 26.6% indicates solid capital efficiency. ROIC of 17.0% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.3% | 29.3% | 27.0% | 27.7% | 31.2% | 31.2% | 37.7% | 36.0% | 35.4% | 32.7% | 26.8% |
| Operating Margin | 16.1% | 16.1% | 13.3% | 12.5% | 12.2% | 12.2% | 20.3% | 18.4% | 10.6% | 12.5% | 2.6% |
| Net Profit Margin | 13.5% | 13.5% | 4.0% | 15.3% | 10.9% | 10.9% | 17.5% | 15.3% | 7.2% | 23.2% | 4.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 26.6% | 26.6% | 6.8% | 24.8% | 18.0% | 20.6% | 33.9% | 24.2% | 10.5% | 45.0% | 9.5% |
| ROA | 15.8% | 15.8% | 4.1% | 14.0% | 9.3% | 11.4% | 21.6% | 18.3% | 8.9% | 37.0% | 6.9% |
| ROIC | 17.0% | 17.0% | 12.6% | 10.3% | 9.5% | 12.8% | 31.7% | 28.9% | 16.5% | 25.2% | 5.4% |
| ROCE | 24.8% | 24.8% | 17.6% | 14.4% | 13.6% | 16.1% | 30.0% | 25.9% | 15.4% | 23.9% | 5.9% |
Solvency and debt-coverage ratios — lower is generally safer
Pro-Dex, Inc. carries a Debt/EBITDA ratio of 1.4x, which is manageable (57% below the sector average of 3.2x). Net debt stands at $16M ($17M total debt minus $419000 cash). Interest coverage of 15.5x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.45 | 0.45 | 0.44 | 0.47 | 0.63 | 0.63 | 0.37 | 0.27 | 0.00 | 0.01 | 0.01 |
| Debt / EBITDA | 1.39 | 1.39 | 1.63 | 2.23 | 2.73 | 2.73 | 0.91 | 0.84 | 0.01 | 0.04 | 0.06 |
| Net Debt / Equity | — | 0.44 | 0.35 | 0.38 | 0.59 | 0.59 | 0.03 | -0.19 | -0.30 | -0.30 | -0.25 |
| Net Debt / EBITDA | 1.35 | 1.35 | 1.31 | 1.79 | 2.58 | 2.58 | 0.08 | -0.59 | -1.75 | -1.24 | -1.97 |
| Debt / FCF | — | — | 2.09 | 2.64 | — | — | 0.11 | -1.65 | -2.38 | -1.57 | -16.96 |
| Interest Coverage | 15.55 | 15.55 | 5.72 | 18.69 | 13.27 | 17.49 | 34.48 | 22.69 | 486.43 | 237.25 | 31.49 |
Short-term solvency ratios and asset-utilisation metrics
Pro-Dex, Inc.'s current ratio of 3.23x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.71x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.23 | 3.23 | 2.84 | 3.20 | 2.74 | 2.74 | 4.34 | 5.10 | 6.40 | 4.62 | 4.44 |
| Quick Ratio | 1.71 | 1.71 | 1.66 | 1.53 | 1.63 | 1.63 | 2.76 | 3.64 | 4.67 | 3.42 | 2.72 |
| Cash Ratio | 0.49 | 0.49 | 0.53 | 0.42 | 0.14 | 0.14 | 1.72 | 2.43 | 2.92 | 1.91 | 1.10 |
| Asset Turnover | — | 1.09 | 1.03 | 0.89 | 0.86 | 0.86 | 1.12 | 1.06 | 1.13 | 1.34 | 1.81 |
| Inventory Turnover | 2.12 | 2.12 | 2.57 | 2.06 | 2.28 | 2.28 | 2.63 | 2.79 | 3.31 | 4.78 | 4.13 |
| Days Sales Outstanding | — | 95.86 | 94.14 | 78.82 | 133.56 | 133.56 | 54.02 | 55.08 | 67.12 | 60.28 | 53.94 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Pro-Dex, Inc. returns 1.7% to shareholders annually primarily through share buybacks. The earnings yield of 4.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | 0.0% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 0.6% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.2% | 6.1% | 3.1% | 10.2% | 7.6% | 3.7% | 8.4% | 7.5% | 5.6% | 20.3% | 3.6% |
| FCF Yield | — | — | 7.4% | 6.5% | — | — | 7.3% | 3.5% | 7.5% | 10.4% | 0.6% |
| Buyback Yield | 1.7% | 2.4% | 5.0% | 2.2% | 2.7% | 4.6% | 4.7% | 7.1% | 0.8% | 1.2% | 2.0% |
| Total Shareholder Yield | 1.7% | 2.4% | 5.0% | 2.2% | 2.7% | 4.6% | 4.7% | 7.2% | 0.8% | 1.2% | 2.0% |
| Shares Outstanding | — | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M |
Compare PDEX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $203M | 23.7 | 18.4 | — | 29.3% | 16.1% | 26.6% | 17.0% | 1.4 | |
| $47M | -185.0 | 24.1 | 22.5 | 15.2% | 1.0% | -0.7% | 1.9% | 6.2 | |
| $9M | -1.0 | — | — | 7.6% | -50.3% | -63.1% | -31.0% | — | |
| $1B | -118.5 | 79.6 | 29.8 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 | |
| $4B | 31.6 | 14.0 | 18.6 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 | |
| $2B | -11.6 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — | |
| $4B | 24.7 | 15.8 | 63.3 | 34.3% | 12.7% | 16.5% | 11.5% | 2.6 | |
| $119B | 36.9 | 21.6 | 27.7 | 64.0% | 19.5% | 15.1% | 11.1% | 2.7 | |
| $17B | 24.7 | 9.8 | 11.6 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 | |
| $104B | 21.6 | 13.7 | 19.1 | 65.0% | 17.8% | 9.8% | 6.4% | 3.0 | |
| $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 | |
| Healthcare Median | — | 22.0 | 14.1 | 18.7 | 63.6% | -4.8% | -32.4% | -11.2% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PDEX stock.
Pro-Dex, Inc.'s current P/E ratio is 23.7x. The historical average is 22.8x. This places it at the 62th percentile of its historical range.
Pro-Dex, Inc.'s current EV/EBITDA is 18.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.7x.
Pro-Dex, Inc.'s return on equity (ROE) is 26.6%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 5.1%.
Based on historical data, Pro-Dex, Inc. is trading at a P/E of 23.7x. This is at the 62th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Pro-Dex, Inc. has 29.3% gross margin and 16.1% operating margin. Operating margin between 10-20% is typical for established companies.
Pro-Dex, Inc.'s Debt/EBITDA ratio is 1.4x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.